Abstract
Our understanding of the pathophysiology of acute coronary syndromes is evolving as the role of prognostic coagulation markers and the different effects unfractionated heparin and low-molecular-weight heparins have on these coagulation markers are investigated. The results of recent clinical trials of low-molecular-weight heparins in acute coronary syndromes are summarized, and an economic evaluation of enoxaparin for these indications is reviewed.
| Original language | English |
|---|---|
| Pages (from-to) | 147S-154S |
| Journal | Pharmacotherapy |
| Volume | 19 |
| Issue number | 9 |
| DOIs | |
| State | Published - 1999 |
Fingerprint
Dive into the research topics of 'Clinical trials of low-molecular-weight heparins in cardiology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver